Walmart Settles Opioid Case, Plans Price Cuts

Monday, August 31, 2026·Consolidated from 5 sources

Walmart has reached a $50 million settlement with the Department of Justice to resolve allegations related to opioid dispensing. Separately, the retailer plans to use tariff refunds to lower prices starting in 2026, a move shared with beauty brand e.l.f. Coverage today also noted unrelated collaborations and executive changes at other retail companies.

Walmart Inc. has agreed to a $50 million settlement with the Department of Justice, addressing allegations concerning its role in dispensing opioid medications. The settlement aims to resolve the government's claims regarding the company's pharmacy practices over several years.

In parallel, Walmart announced plans to implement price reductions on select items beginning in 2026. This initiative is expected to be funded in part by tariff refunds. The company is collaborating with beauty brand e.l.f. Beauty on this strategy, with both entities looking to pass savings onto consumers.

While this news emerged today, other retail sector developments were also reported. These included partnerships and product launches by various brands, such as a new summer-themed collaboration between Duke Cannon and Mountain Dew. Additionally, Gap Inc. announced a new CEO for its Old Navy division, signaling a shift in its marketing leadership.

These announcements come as the retail landscape continues to evolve, with companies navigating regulatory issues, consumer pricing strategies, and internal organizational changes to maintain market competitiveness.

Sources